Jamaica’s Pure Jamaican and Seven Ten Limited Forge Path in Global Cannabis Market

LOS ANGELES- In a significant stride towards global market leadership, Pure Jamaican has initiated a groundbreaking program aimed at exporting its distinctive pharmaceutical products. This includes a range of cannabinoid compounds such as THC derived from cannabis and CBD from hemp. This ambitious venture is set to impact major international markets, notably the USA and Brazil, positioning Jamaica as a frontrunner in the rapidly evolving global cannabis industry.

Strategic Collaboration Elevates Jamaica’s Global Presence

The collaboration between Pure Jamaican and Seven Ten Limited marks a pivotal moment in Jamaica’s cannabis sector. With the green light from Jamaica’s Ministry of Health & Wellness and the endorsement of Seven-10 Pharmaceuticals by the US Drug Enforcement Administration (DEA), this partnership is set to expand Jamaica’s footprint in the lucrative American cannabis market. This move is not just about market expansion but also signifies the potential of strategic alliances in boosting Jamaica’s standing on the global stage.

Anticipating future shifts in the DEA’s classification of THC, Seven-10 is gearing up to seek permits for exporting Pure Jamaican’s THC-based pharmaceuticals to the US. This forward-looking approach promises to open up new avenues for international collaborations and business opportunities, further solidifying Jamaica’s pivotal role in the global medical cannabis landscape.

A Milestone in Medicinal Cannabis Export

Currently, Seven-10 has commenced the export of THC and cannabinoid-infused pharmaceutical tinctures under the Botanicos™ brand of Pure Jamaican, directly benefiting patients in Brazil. This achievement underscores the effective role of JAMPRO, Jamaica’s trade, and investment promotion agency, in nurturing the country’s medicinal cannabis industry and promoting export growth.

Beyond cannabis, Pure Jamaican is venturing into the export of a wide array of botanicals, including pharmaceuticals, nutraceuticals, and active pharmaceutical ingredients (APIs). Their goal is to tap into the rich biodiversity of Jamaica, offering a comprehensive range of plant-based products to the global market, thereby enhancing Jamaica’s standing in international commerce.

Pure Jamaican & Seven Ten Limited: Pioneers on the Global Stage

As entities committed to showcasing Jamaican cannabis and botanicals globally, Pure Jamaican and Seven Ten Limited are at the forefront of innovation in pharmaceuticals, nutraceuticals, and APIs. Their pioneering efforts are expanding Jamaica’s influence worldwide, setting a benchmark for future endeavors in this dynamic field.

The success of Pure Jamaican in exporting its proprietary pharmaceutical products, encompassing THC from cannabis and CBD from hemp, to key markets worldwide, underscores the untapped potential of Jamaica’s cannabis sector. This venture not only propels local companies into significant markets like the United States and Brazil but also exemplifies the impact of focused strategies, collaborative efforts, and governmental support through agencies like JAMPRO.

As Jamaica’s cannabis industry embarks on this promising journey, the achievements of Pure Jamaican and Seven Ten Limited highlight a future ripe with growth, innovation, and an enhanced global presence. This advancement in the exportation of medicinal cannabis and botanicals is poised to bolster Jamaica’s international profile, marking a new era of prosperity and innovation for the nation.